» Articles » PMID: 33043074

Movement Disorders and Renal Diseases

Overview
Publisher Wiley
Specialty Neurology
Date 2020 Oct 12
PMID 33043074
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Movement disorders often emerge from the interplay of complex pathophysiological processes involving the kidneys and the nervous system. Tremor, myoclonus, ataxia, chorea, and parkinsonism can occur in the context of renal dysfunction (azotemia and electrolyte abnormalities) or they can be part of complications of its management (dialysis and renal transplantation). On the other hand, myoglobinuria from rhabdomyolysis in status dystonicus and certain drugs used in the management of movement disorders can cause nephrotoxicity. Distinct from these well-recognized associations, it is important to appreciate that there are several inherited and acquired disorders in which movement abnormalities do not occur as a consequence of renal dysfunction or vice versa but are manifestations of common pathophysiological processes affecting the nervous system and the kidneys. These disorders are the emphasis of this review. Increasing awareness of these conditions among neurologists may help them to identify renal involvement earlier, take timely intervention by anticipating complications and focus on therapies targeting common mechanisms in addition to symptomatic management of movement disorders. Recognition of renal impairment in a patient with complex neurological presentation may narrow down the differentials and aid in reaching a definite diagnosis.

Citing Articles

Association between kidney function and Parkinson's disease risk: a prospective study from the UK Biobank.

Peng H, Wu L, Chen Q, Chen S, Wu S, Shi X BMC Public Health. 2024; 24(1):2225.

PMID: 39148063 PMC: 11328353. DOI: 10.1186/s12889-024-19709-x.


Beyond the kidney: extra-renal manifestations of monogenic nephrolithiasis and their significance.

Wu C, Badreddine J, Su E, Tay K, Lin H, Rhodes S Pediatr Nephrol. 2023; 39(5):1429-1434.

PMID: 38057433 DOI: 10.1007/s00467-023-06242-z.


Orofacial Dyskinesia in Uremia in Polycystic Kidney Disease.

Arora N, Mehdi Z, DCruz S, Sharma I J Emerg Trauma Shock. 2023; 16(3):130-132.

PMID: 38025501 PMC: 10661570. DOI: 10.4103/jets.jets_8_23.


Unmasking Uremic Encephalopathy: Choreoathetoid Movements Mimicking Alcohol Withdrawal in a Person with an Alcohol Use Disorder.

Saboo K, Gemnani R, Acharya S, Kumar S, Sontakke T Cureus. 2023; 15(10):e47387.

PMID: 38022070 PMC: 10659565. DOI: 10.7759/cureus.47387.


Thalamic Neuron Resilience during Osmotic Demyelination Syndrome (ODS) Is Revealed by Primary Cilium Outgrowth and ADP-ribosylation factor-like protein 13B Labeling in Axon Initial Segment.

Gilloteaux J, De Swert K, Suain V, Nicaise C Int J Mol Sci. 2023; 24(22).

PMID: 38003639 PMC: 10671465. DOI: 10.3390/ijms242216448.


References
1.
Perandones C, Micheli F, Pellene L, Bayly M, Berkovic S, Dibbens L . A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2. Mov Disord. 2012; 27(9):1200-1. DOI: 10.1002/mds.25083. View

2.
Galloway W, Mowat A . Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet. 1968; 5(4):319-21. PMC: 1468664. DOI: 10.1136/jmg.5.4.319. View

3.
Joubert M, Eisenring J, Robb J, Andermann F . Familial agenesis of the cerebellar vermis. A syndrome of episodic hyperpnea, abnormal eye movements, ataxia, and retardation. Neurology. 1969; 19(9):813-25. DOI: 10.1212/wnl.19.9.813. View

4.
Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S . A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet. 2006; 78(2):345-9. PMC: 1380241. DOI: 10.1086/500092. View

5.
Dibbens L, Karakis I, Bayly M, Costello D, Cole A, Berkovic S . Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy. Arch Neurol. 2011; 68(6):812-3. DOI: 10.1001/archneurol.2011.120. View